Douglas M Lopes
Douglas M Lopes
1Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, Paul O’Gorman Building, 72 Huntley Street, London, WC1E 6DD UK
1,
Jack A Wells
Jack A Wells
1Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, Paul O’Gorman Building, 72 Huntley Street, London, WC1E 6DD UK
1,
Da Ma
Da Ma
2Department of Internal Medicine, Section of Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, NC USA
2,
Lauren Wallis
Lauren Wallis
1Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, Paul O’Gorman Building, 72 Huntley Street, London, WC1E 6DD UK
1,
Daniel Park
Daniel Park
1Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, Paul O’Gorman Building, 72 Huntley Street, London, WC1E 6DD UK
1,
Sophie K Llewellyn
Sophie K Llewellyn
1Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, Paul O’Gorman Building, 72 Huntley Street, London, WC1E 6DD UK
1,
Zeshan Ahmed
Zeshan Ahmed
3Neuroscience Next Generation Therapeutics (NGTx), Eli Lilly and Company, Cambridge, MA USA
3,
Mark F Lythgoe
Mark F Lythgoe
1Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, Paul O’Gorman Building, 72 Huntley Street, London, WC1E 6DD UK
1,
Ian F Harrison
Ian F Harrison
1Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, Paul O’Gorman Building, 72 Huntley Street, London, WC1E 6DD UK
1,✉
1Centre for Advanced Biomedical Imaging, Department of Imaging, Division of Medicine, University College London, Paul O’Gorman Building, 72 Huntley Street, London, WC1E 6DD UK
2Department of Internal Medicine, Section of Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston-Salem, NC USA
3Neuroscience Next Generation Therapeutics (NGTx), Eli Lilly and Company, Cambridge, MA USA
© The Author(s) 2024
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
